TITLE:
Missing the Target?—Targeted Therapy in Small Cell Lung Cancer
AUTHORS:
Karin R. Purshouse
KEYWORDS:
Oncology, Small Cell Lung Cancer, Targeted Therapy, Drug Development
JOURNAL NAME:
Advances in Lung Cancer,
Vol.3 No.3,
August
22,
2014
ABSTRACT: Small
cell lung cancer [SCLC] is a devastating form of cancer, with most patients
harbouring extensive disease at diagnosis and survival of less than 5% at five
years. Progress in novel therapies has been limited. This specialist review
explores current targeted therapy options and potential areas of development.